![Frontiers | Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience Frontiers | Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience](https://www.frontiersin.org/files/Articles/788213/fonc-12-788213-HTML/image_m/fonc-12-788213-g001.jpg)
Frontiers | Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience
![PDF] Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial | Semantic Scholar PDF] Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e43b07e4960477c6f22aa93712ff84aeb1f55fb2/184-Table6.1-1.png)
PDF] Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial | Semantic Scholar
![New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer | British Journal of Cancer New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01440-8/MediaObjects/41416_2021_1440_Fig1_HTML.png)
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer | British Journal of Cancer
![Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial - The Lancet Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/6b1ccafd-5c87-480e-9d16-f45808cd6c01/gr3_lrg.gif)
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial - The Lancet
![Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/370/bmj.m2836/F4.medium.jpg)
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ
![Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/370/bmj.m2836/F5.medium.jpg)
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ
![Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/370/bmj.m2836/F1.large.jpg)
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ
![Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ](https://cf-images.eu-west-1.prod.boltdns.net/v1/static/2696240571001/23c98507-6fe4-4f9c-bdd5-b07dfdf44e96/7b64136d-c0d8-451b-b84d-dcf151629cd2/1280x720/match/image.jpg)
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ
![TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients TARGIT-A randomised clinical phase-III trial of single-dose IORT (TARGIT-IORT) for early-stage breast cancer patients](https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/iort/457-the-targit-a-trial-from-the-perspective-of-an-american-radiation-oncologist-effectiveness-efficiency-and-highest-scientific-standards-/teaser-image-targit-a-webinar-uhl.png/_jcr_content/renditions/original./teaser-image-targit-a-webinar-uhl.png)